Communication
RSC Advances
N-phenylhydrazonoyl hydrochloride 7c with amido group, 7d
with ethyl group, and 7e with phenyl group did not give the
corresponding 1,2,4-triazole 8c–e (entries 3–5 in Table 4).
Decomposition of the starting materials was observed. The
results in Table 4 indicated the one-ask 1,3-dipolar cycload-
dition strategy was applicable to N-phenylhydrazonoyl hydro-
chlorides bearing ester and acetyl functionalities.
2 (a) K. T. Potts, Chem. Rev., 1961, 6, 87–127; (b) A. Moulin,
M. Bibian, A.-L. Blayo, S. E. Habnouni, J. Martinez and
J.-A. Fehrentz, Chem. Rev., 2010, 110, 1809–1827.
3 K.-S. Yeung, M. E. Farkas, J. F. Kadow and N. A. Meanwell,
Tetrahedron Lett., 2005, 46, 3429–3432.
4 A. Neelima and A. P. Bhaduri, Indian J. Chem., 1983, 22B,
79–80.
We proposed a plausible mechanism for the one-ask
synthesis of 1,3,5-trisubstituted 1,2,4-triazoles from nitriles
and N-arylhydrazonoyl chlorides through a new 1,3-dipolar
cycloaddition in Scheme 1. Upon reaction with EtOH in the
presence of HCl(g), nitrile 5 was converted to its corre-
sponding imidate 6. N-Arylhydrazonoyl 3 was converted to
the corresponding nitrilimine 8 by Et3N in the same ask,
then the 1,3-dipolar cycloaddition between dipolarophile 6
and 1,3-dipole 9 took place to generate cyclic intermediate
10. Aromatization of 10 by releasing EtOH generated 1,2,4-
triazole 4 in one ask.
5 (a) P. H. Olesen, A. R. Sorensen, B. Urso, P. Kurtzhals,
A. N. Bowler, U. Ehrbar and B. F. Hansen, J. Med. Chem.,
2003, 46, 3333–3341; (b) H. J. Breslin, T. A. Miskowski,
M. J. Kukla, H. J. De Winter, M. V. F. Somers,
P. W. M. Roevens and R. W. D. Kavash, Bioorg. Med. Chem.
Lett., 2003, 13, 4467–4471; (c) J. J. Baldwin, P. A. Kasinger,
F. C. Novello, J. M. Spradue and D. E. Duggen, J. Med.
Chem., 1975, 18, 895–900.
6 (a) D. B. Reitz and M. J. Finkes, J. Heterocycl. Chem., 1989, 26,
225–230; (b) A. Kakefuda, T. Suzuki, T. Tobe, A. Tahara,
S. Sakamoto and S. Tsukamoto, Bioorg. Med. Chem., 2002,
10, 1905–1912; (c) N. I. Korotkikh, A. V. Kiselev,
A. V. Knishevitsky, G. F. Raenko, T. M. Pekhtereva and
O. P. Shvaika, Chem. Heterocycl. Compd., 2005, 41, 866–871;
(d) S. Olson, S. D. Aster, K. Brown, L. Carbin,
D. W. Graham, A. Hermanowski-Vosatka, C. B. LeGrand,
S. S. Mundt, M. A. Robbins, J. M. Schaeffer,
L. H. Slossberg, M. J. Szymonia, R. Thieringer,
S. D. Wright and J. M. Balkovec, Bioorg. Med. Chem. Lett.,
2005, 15, 4359–4362; (e) A. Brown, D. Ellis, D. Pearce,
M. Ralph and N. Sciammetta, Bioorg. Med. Chem. Lett.,
2009, 19, 2634–2636; (f) T. Sugane, T. Tobe, W. Hamaguchi,
I. Shimada, K. Maeno, J. Miyata, T. Suzuki, T. Kimizuka,
A. Kohara, T. Morita, H. Doihara, K. Saita, M. Aota,
M. Furutani, Y. Shimada, N. Hamada, S. Sakamoto and
S. Tsukamoto, J. Med. Chem., 2011, 54, 387–391.
Conclusions
We developed a one-ask methodology for the synthesis 1,3,5-
trisubstituted 1,2,4-triazoles using nitriles and N-arylhy-
drazonoyl chlorides as the starting materials. The reaction was
applicable to aliphatic and aromatic nitriles with N-arylhy-
drazonoyl chlorides bearing various substituents on the phenyl
group. A plausible 1,3-dipolar cycloaddition mechanism was
proposed for the reaction of imidate from nitrile with nitrili-
mine from hydrazonoyl chloride in one ask to generate the
desired 1,2,4-triazole.
Acknowledgements
We are grateful to the China Medical University (CMU100-ASIA-
17 and CMU101-S-23), Tsuzuki Institute for Traditional Medi-
cine, and the National Science Council of Republic of China for
nancial support (NSC-99-2320-B-039-014-MY3 and 102-2113-
M-415-005-MY2).
7 (a) L.-Y. Wang, W.-C. Tseng, T.-S. Wu, K. Kaneko, M. Kimura,
H. Takayama, W.-C. Yang, J. B. Wu, S.-H. Juang and
F. F. Wong, Bioorg. Med. Chem. Lett., 2011, 21, 5358–5362;
(b) L.-Y. Wang, W.-C. Tseng, H.-Y. Lin and F. F. Wong,
Synlett, 2011, 1467–1471; (c) W.-C. Tseng, L.-Y. Wang,
T.-S. Wu and F. F. Wong, Tetrahedron, 2011, 67, 5339–5345.
8 (a) J. A. Pfefferkorn, C. Choi, S. D. Larsen, B. Auerbach,
R. Hutchings, W. Park, V. Askew, L. Dillon,
J. C. Hanselman, Z. Lin, G. H. Lu, A. Robertson,
C. Sekerke, M. S. Harris, A. Pavlovsky, G. Bainbridge,
N. Caspers, M. Kowala and B. D. Tait, J. Med. Chem., 2008,
51, 31–45; (b) R. Silvestri, M. G. Cascio, G. L. Regina,
F. Piscitelli, A. Lavecchia, A. Brizzi, S. Pasquini, M. Botta,
E. Novellino, V. D. Marzo and F. Corelli, J. Med. Chem.,
2008, 51, 1560–1576; (c) D. J. P. Pinto, M. J. Orwat, S. Koch,
K. A. Rossi, R. S. Alexander, A. Smallwood, P. C. Wong,
A. R. Rendina, J. M. Luettgen, R. M. Knabb, K. He, B. Xin,
R. R. Wexler and P. Y. S. Lam, J. Med. Chem., 2007, 50,
5339–5356.
Notes and references
1 (a) C. Temple, Jr, The Chemistry of Heterocyclic Compounds:
Triazoles 1,2,4, Wiley, New York, NY, 1981, vol. 37; (b)
I. A. Al-Masoudi, Y. A. Al-Soud, N. J. Al-Salihi and N. A. Al-
Masoudi, Chem. Heterocycl. Compd., 2006, 42, 1605–1634;
(c) A. Curtis and N. Jennings, in Comprehensive Heterocyclic
Chemistry III, ed. A. R. Katritzky, C. A. Ramsden, E. F. V.
Scriven and R. J. K. Taylor, Elsevier Ltd, New York, NY,
2008, vol. 5; (d) K. Shalini, N. Kumar, S. Drabu and
P. K. Sharma, Beilstein J. Org. Chem., 2011, 7, 668–677; (e)
N. Singhal, P. K. Sharma, R. Dudhe and N. Kumar, J. Chem.
Pharm. Res., 2011, 3, 126–133; (f) N. Lebouvier, F. Giraud,
T. Corbin, Y. M. Na, G. Le Baut, P. Marchand and M. Le
Borgne, Tetrahedron Lett., 2006, 47, 6479–6483; (g)
L. Navidpour, H. Shadnia, H. Shafaroodi, M. Amini,
A. R. Dehpour and A. Shaee, Bioorg. Med. Chem., 2007, 15,
1976–1982.
9 (a) L. M. Oh, Tetrahedron Lett., 2006, 47, 7943–7946; (b) B. El
Azzaoui, B. Rachid, M. L. Doumbia, E. M. Essassi,
H. Gornitzka and J. Bellan, Tetrahedron Lett., 2006, 47,
8807–8810; (c) S. R. Donohue, C. Halldin and V. W. Pikc,
Tetrahedron Lett., 2008, 49, 2789–2791; (d) A. M. Farag,
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 14215–14220 | 14219